Krebs Biochemicals & Industries Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 116.46 million compared to INR 113.92 million a year ago. Revenue was INR 121.12 million compared to INR 167.66 million a year ago. Net loss was INR 108.49 million compared to INR 63.9 million a year ago. Basic loss per share from continuing operations was INR 5.05 compared to INR 3.26 a year ago. Diluted loss per share from continuing operations was INR 5.05 compared to INR 3.26 a year ago.
For the six months, sales was INR 170.41 million compared to INR 190.72 million a year ago. Revenue was INR 188.97 million compared to INR 283.85 million a year ago. Net loss was INR 202.72 million compared to INR 131.12 million a year ago. Basic loss per share from continuing operations was INR 9.42 compared to INR 6.68 a year ago. Diluted loss per share from continuing operations was INR 9.42 compared to INR 6.68 a year ago.